T1	Participants 51 89	atrial fibrillation or atrial flutter.
T2	Participants 217 317	45 patients with atrial fibrillation or atrial flutter, in a randomized, parallel, open-label study.
T3	Participants 318 500	Patients with either new onset (less than 48 hours, n = 31) or old onset (greater than 48 hours, n = 14) of atrial fibrillation or flutter with rapid ventricular rate were stratified
